...
首页> 外文期刊>Neurodegenerative disease management >Advances in Abeta plaque detection and the value of knowing: overcoming challenges to improving patient outcomes in Alzheimer's disease
【24h】

Advances in Abeta plaque detection and the value of knowing: overcoming challenges to improving patient outcomes in Alzheimer's disease

机译:Abeta Plaque检测的进展和知识的价值:克服挑战改善阿尔茨海默病的患者结果

获取原文
获取原文并翻译 | 示例
           

摘要

Clinical diagnosis of Alzheimer's disease (AD) can be challenging as numerous diseases mimic the characteristics of AD. In this light, recent guidelines developed by different associations and working groups point out the need for biomarkers to support AD diagnosis. This paper discusses 18F-labeled radiotracers (which are indicated for PET imaging of the brain) and ongoing clinical studies that aim to generate new evidence for the usage of amyloid imaging. In addition to their relatively long half-life, these agents are known for their high sensitivity and high negative predictive values for detection of neuritic Ap plaques. Comparisons with other biomarkers are provided and implications of diagnostic disclosures discussed. Finally, recent data from clinical trials underscore the importance of amyloid PET for detecting, quantifying and monitoring Abeta plaque deposits.
机译:None

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号